The concentrate

Danaher owns four critical IVD supply nodes

A single conglomerate has consolidated nitrocellulose membranes, oligonucleotide probes, filtration media, and microfluidic components through strategic acquisitions.

The number

4independent critical nodes

Danaher's ownership of Cytiva, IDT, Pall, and IDEX creates a concentration risk across the in-vitro diagnostics manufacturing chain. A single supply disruption—geopolitical, operational, or regulatory—now cascades across multiple independent nodes that diagnostic manufacturers depend on.

Source: Cytiva | Danaher · Danaher Corporation · Jan 1, 2024

Jump into the supply map

Where this story connects

The supplymap lets you trace the goods, inputs, and companies this story touches — see the full dependency chain, country shares, and historical incidents.

Essential goods

Tap to see the full chain

Diagnostic tests and lab supplies →
health
Ophthalmic and eye Rx products →
health
Vaccines →
health

Raw inputs

Tap for sourcing data

0.22-μm Sterilizing-grade Membrane Filters (PVDF/PTFE/PES) →
manufactured
Glass Fiber Conjugate Pads & Borosilicate Fiber Membranes →
manufactured
Nitrocellulose (NC) Membrane for Lateral Flow →
manufactured
Single-Use Bioreactor Bags (Cellbag) →
manufactured

More on Producer · Danaher Corporation / Cytiva (Whatman brand)

Danaher owns four critical IVD supply nodes

Where this story connects

Related stories